Bank of Montreal’s AstraZeneca AZN Stock Holding History

Bank of Montreal’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-104,750	Closed	-$10.6M	–	5061
2020 Q4	$10.6M	Buy	+104,750	New	+$11.1M	0.01%	985
2017 Q3	–	Sell	-50,400	Closed	-$3.44M	–	4153
2017 Q2	$3.44M	Buy	+50,400	New	+$3.29M	﹤0.01%	1341
2016 Q3	–	Sell	-79	Closed	-$5K	–	4011
2016 Q2	$5K	Buy	+79	New	+$4.59K	﹤0.01%	3721
2016 Q1	–	Sell	-7,900	Closed	-$536K	–	4179
2015 Q4	$536K	Hold	7,900	–	–	﹤0.01%	1962
2015 Q3	$503K	Buy	+7,900	New	+$520K	﹤0.01%	1845
2015 Q1	–	Sell	-60,000	Closed	-$4.22M	–	3969
2014 Q4	$4.22M	Sell	60,000 -25,000	-29%	-$1.79M	﹤0.01%	1095
2014 Q3	$6.07M	Buy	85,000 +53,000	+166%	+$3.88M	0.01%	1016
2014 Q2	$2.38M	Buy	+32,000	New	+$2.31M	﹤0.01%	1389

Other funds holding AZN

EPGL

Evelyn Partners Group Ltd London $46.9B AUM

Norges Bank Oslo, Norway $1T AUM

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return

Bank of Montreal's AZN Position: Q2 2026 in Review

Bank of Montreal increased its AstraZeneca (AZN) stake by 23% in Q2 2026, buying an estimated $81.5M and bringing the position to 2,359,807 shares worth $441M. The position accounts for 0.15% of the portfolio, ranked #124.

Bank of Montreal first reported a position in AZN in Q2 2013 and has held it in 53 quarters since. 1,068 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Bank of Montreal held 2,359,807 shares of AstraZeneca worth $441M as of Q2 2026.
Bank of Montreal bought 433,492 AstraZeneca shares in Q2 2026, an estimated $81.5M.
AstraZeneca made up 0.15% of Bank of Montreal's portfolio in Q2 2026, its #124 holding.
Bank of Montreal first reported a position in AstraZeneca in Q2 2013 and has held it in 53 quarters since.
1,068 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.